Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 12:09 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1297–1320 of 3,580 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: patch Clear all

Conditions: Healthspan Improvement, Aging, Longevity
Interventions: Rapamycin, Naltrexone, Metformin, NAD+, GSH, Infinite Supplement, Placebo/control, B12, Intervention: Guided Meditation Program, Control: Podcast Listening Activity, Control: Standard Exercise Regimen, Intervention: Structured Exercise Program; Drug · Dietary Supplement · Behavioral
Lead sponsor: AgelessRx; Industry
Eligibility: 60 Years to 80 Years
Enrollment: 26 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Opioid Withdrawal, Chronic Pain
Interventions: Buprenorphine Patch, Placebo, Transcranial Magnetic Stimulation (TMS), Sham Transcranial Magnetic Stimulation (TMS); Drug · Device
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 240 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2029
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Tobacco Use Cessation
Interventions: Nicotine patch, Varenicline, Nicotine metabolism, Genetically-informed lung cancer risk score, NCI "Clearing the Air"; Drug · Genetic · Behavioral
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 67 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Geographic Atrophy From Age-related Macular Degeneration
Interventions: Not listed
Lead sponsor: University of Utah; Other
Eligibility: 65 Years to 90 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Tobacco Dependence
Interventions: C-Raven Virtual Tobacco Cessation Counseling, Nicotine Replacement Product, Community Health Worker, Lung Cancer Screening; Behavioral · Drug · Other
Lead sponsor: Johns Hopkins University; Other
Eligibility: 50 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Carcinoma, Non-Small-Cell Lung
Interventions: Bronchoscopic Biopsy, Blood Sample; Other
Lead sponsor: Janssen Research & Development, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 2
States / cities: Washington D.C., District of Columbia • Buffalo, New York

Conditions: Keloid
Interventions: Dupilumab, Placebo; Drug
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: New York, New York

Conditions: Osteogenic Sarcoma Recurrent
Interventions: Iscador*P; Drug
Lead sponsor: Hackensack Meridian Health; Other
Eligibility: 8 Years to 30 Years
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 2
States / cities: Hackensack, New Jersey • Houston, Texas

Conditions: Colitis, Lung Non-Small Cell Carcinoma, Malignant Genitourinary System Neoplasm, Malignant Solid Neoplasm, Melanoma
Interventions: Infliximab, Vedolizumab; Biological
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 47 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Asthma in Children, Asthma Attack
Interventions: Wearable stethoscope, Routine Clinical lung Auscultation; Device · Other
Lead sponsor: Emory University; Other
Eligibility: 6 Years to 17 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Tobacco Dependence
Interventions: Placebo (sugar pill), Topiramate, Nicotine patch; Drug
Lead sponsor: UConn Health; Other
Eligibility: 18 Years to 65 Years
Enrollment: 57 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2013
U.S. locations: 1
States / cities: Farmington, Connecticut

Conditions: Menopause, Aging
Interventions: Elagolix Oral Tablet, Estradiol patch, cellulose placebo, placebo patch; Drug · Other
Lead sponsor: Penn State University; Other
Eligibility: 42 Years to 64 Years · Female only
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: University Park, Pennsylvania

Conditions: Atherosclerosis
Interventions: Atorvastatin; Drug
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 18 Years to 85 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2010
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Dysphagia, Stroke, Parkinson Disease
Interventions: In-person sEMG-biofeedback, Remote sEMG-biofeedback, Standard-of-care treatment; Behavioral
Lead sponsor: University of Illinois at Urbana-Champaign; Other
Eligibility: 50 Years to 90 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 2
States / cities: Champaign, Illinois • West Lafayette, Indiana

Conditions: Cervical Lesions
Interventions: Self etch enamel etching, selective etch protocol, Adhese Universal; Procedure · Device
Lead sponsor: Indiana University; Other
Eligibility: 20 Years to 75 Years
Enrollment: 33 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2018
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Smoking Cessation
Interventions: SmokefreeSGM; Behavioral
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Anal Cancer
Interventions: Not listed
Lead sponsor: Laser Surgery Care; Other
Eligibility: 18 Years to 85 Years · Male only
Enrollment: 195 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: New York, New York

Conditions: Breast Cancer
Interventions: Biomarkers; Other
Lead sponsor: Sentara Norfolk General Hospital; Other
Eligibility: 18 Years and older · Female only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Newport News, Virginia

Conditions: Nausea With Vomiting Chemotherapy-Induced
Interventions: Granisetron Transdermal Patch, Intravenous Dexamethasone, Ondansetron; Drug
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years to 75 Years
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2028
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Tooth Demineralization
Interventions: MI Paste Plus, PreviDent Fluoride Varnish, Normal Home Care; Procedure
Lead sponsor: University of Washington; Other
Eligibility: 12 Years to 20 Years
Enrollment: 240 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Nicotine Dependence
Interventions: Nicotine Patch, Moclobemide; Drug
Lead sponsor: Jed E. Rose; Other
Eligibility: 18 Years to 65 Years · Female only
Enrollment: 76 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 3
States / cities: Charlotte, North Carolina • Durham, North Carolina • Winston-Salem, North Carolina

Conditions: Cutaneous T-Cell Lymphoma/Mycosis Fungoides
Interventions: Hypericin, Mechlorethamine Topical Gel; Drug
Lead sponsor: Soligenix; Industry
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Fairport, New York

Conditions: Dental Caries, Quality of Life
Interventions: Silver Diamine Fluoride, Fluoride Varnishes, Glass Ionomer; Device
Lead sponsor: NYU College of Dentistry; Other
Eligibility: 5 Years to 12 Years
Enrollment: 7,418 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: New York, New York

Conditions: Kaposi's Sarcoma
Interventions: Not listed
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years to 100 Years
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2017
U.S. locations: 1
States / cities: Bethesda, Maryland

Search by objective public record fields.

Combination Gerotherapeutic Interventions for Healthspan Improvement

ACTION: Trial of Adding Buprenorphine, CBT, and TMS to Improve Outcomes of Long-Term Opioid Therapy for Chronic Pain

PRecision Interventions for SMoking in the SCCS

Lesion-tailored, Fundus-controlled Perimetry in Geographic Atrophy (GA).

C-Raven, a Virtual Tobacco Cessation Intervention in the Community

A Study to Examine Biomarkers From Lung and Blood Samples in Participants With Suspected Lung Cancer

Dupilumab in the Treatment of Keloids

Iscador® P (Mistletoe) Immunotherapy for Recurrent Resectable Osteogenic Sarcoma

Infliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or Melanoma

Wearable Electronic Breath Sound Sensing Device

Topiramate Alone and in Combination With the Nicotine Patch for Smoking Cessation: A Pilot Study

Role of Menopause in Thermoregulation

Effect of Short Term Atorvastatin Treatment,80mg/Day on Early Regression of Carotid Artery Atherosclerotic Lesions

Wearable Biofeedback for Swallowing Disorders Rehabilitation in Stroke and Parkinson Disease

Clinical Evaluation of a Universal Adhesive in Noncarious Cervical Lesions

SmokefreeSGM Español Pilot, Beta Testing a Text-based Smoking Cessation Intervention for Sexual and Gender Minority(SGM) Groups Preferring Spanish Language

Assessing Drivers and Barriers to Follow-Up Screening for Anal Cancer in Men Who Have Sex With Men

Novel Molecular Targets for Ductal Carcinoma In Situ (DCIS)

BMT-08: A Comparative Effectiveness Study of Transdermal Granisetron to Ondansetron

Study of Treatments Used for White Spot Lesions After Orthodontic Treatment.

Evaluation of Moclobemide, a Reversible MAO-A Inhibitor, as an Adjunct to Nicotine Replacement Therapy in Female Smokers

HyBryte (Synthetic Hypericin) Versus Valchlor (Mechlorethamine) in the Treatment of CTCL

Comparative Effectiveness of School-based Caries Prevention

Assessment of Blood Vessel Density in Kaposi's Sarcoma Lesions